NIPH
PFE icon

NN Investment Partners Holdings’s Pfizer PFE Stock Holding History

NN Investment Partners Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$54.1M Sell
1,044,847
-774,759
-43% -$40.2M 0.29% 67
2021
Q4 		$107M Buy
1,819,606
+835,765
+85% +$41.4M 0.54% 41
2021
Q3 		$42.3M Sell
983,841
-246,329
-20% -$10.9M 0.23% 78
2021
Q2 		$48.2M Buy
1,230,170
+87,539
+8% +$3.4M 0.26% 72
2021
Q1 		$41.4M Buy
1,142,631
+72,904
+7% +$2.59M 0.24% 76
2020
Q4 		$39.4M Sell
1,069,727
-769,215
-42% -$28.2M 0.24% 75
2020
Q3 		$62.5M Buy
1,838,942
+63,172
+4% +$2.21M 0.4% 48
2020
Q2 		$55.1M Sell
1,775,770
-68,574
-4% -$2.33M 0.37% 55
2020
Q1 		$57.1M Sell
1,844,344
-473,871
-20% -$16.1M 0.47% 45
2019
Q4 		$86.2M Buy
2,318,215
+250,264
+12% +$8.91M 0.59% 34
2019
Q3 		$70.5M Sell
2,067,951
-1,654,038
-44% -$60.1M 0.55% 40
2019
Q2 		$153M Sell
3,721,989
-1,515,797
-29% -$60.2M 1.21% 13
2019
Q1 		$211M Buy
5,237,786
+715,527
+16% +$28.7M 1.65% 11
2018
Q4 		$187M Sell
4,522,259
-745,983
-14% -$31M 1.59% 11
2018
Q3 		$220M Sell
5,268,242
-540,613
-9% -$20.8M 1.59% 10
2018
Q2 		$200M Buy
5,808,855
+11,196
+0.2% +$383K 1.46% 12
2018
Q1 		$195M Buy
5,797,659
+1,408,859
+32% +$48.4M 1.4% 11
2017
Q4 		$151M Sell
4,388,800
-793,874
-15% -$27.1M 1.07% 22
2017
Q3 		$176M Buy
5,182,674
+20,708
+0.4% +$666K 1.12% 16
2017
Q2 		$165M Sell
5,161,966
-1,183,853
-19% -$37.3M 1.52% 8
2017
Q1 		$206M Sell
6,345,819
-1,633,779
-20% -$51.5M 1.95% 5
2016
Q4 		$246M Sell
7,979,598
-277,717
-3% -$8.48M 2.32% 3
2016
Q3 		$265M Buy
8,257,315
+167,483
+2% +$5.6M 2.49% 3
2016
Q2 		$270M Sell
8,089,832
-520,788
-6% -$16.6M 2.55% 2
2016
Q1 		$242M Buy
+8,610,620
New +$246M 2.32% 3

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

NN Investment Partners Holdings's PFE Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Pfizer (PFE) stake by 43% in Q1 2022, selling an estimated $40.2M and leaving 1,044,847 shares worth $54.1M. The position accounts for 0.29% of the portfolio, ranked #67.

NN Investment Partners Holdings first reported a position in PFE in Q1 2016 and has held it in 25 quarters since. The position peaked at $270M in Q2 2016. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • NN Investment Partners Holdings held 1,044,847 shares of Pfizer worth $54.1M as of Q1 2022.
  • NN Investment Partners Holdings sold 774,759 Pfizer shares in Q1 2022, an estimated $40.2M.
  • Pfizer made up 0.29% of NN Investment Partners Holdings's portfolio in Q1 2022, its #67 holding.
  • NN Investment Partners Holdings first reported a position in Pfizer in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's Pfizer position peaked at $270M in Q2 2016.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.